• Thursday, March 28, 2024

News

Glenmark’s antiviral tablets get approval for clinical trials on COVID-19 patients

The Drug Controller General of India (DCGI) has given the nod for clinical trials of Glenmark Pharmaceuticals’ Favipiravir antiviral tablets on COVID-19 patients, the company said on Thursday (30). Glenmark…